Streetbeat News

Legal

MDXXF

PharmAla Biotech Holdings (OTC:MDXXF) has been granted a US patent for ALA-002, a novel MDMA mixture, by the USPTO. This patent covers the composition of ALA-002, a mixture of MDMA enantiomers aimed at reducing adverse effects and addiction potential while improving pro-social effects. The company plans to pursue clinical research for treating social anxiety in Autism Spectrum Disorder and other neurological disorders, leveraging this patent to accelerate global IP efforts.

Portfolio Pulse from Lara Goldstein

March 27, 2024 | 10:56 pm

CC

Chemours disclosed material weaknesses in its internal controls and a remediation plan in its Annual Report on Form 10-K. The Audit Committee's review found a lack of transparency by three former senior management members.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 9:36 pm

JNJ

A federal judge has granted Johnson & Johnson a new opportunity to challenge the scientific evidence connecting its talc products to ovarian cancer. This decision could impact a federal court case that consolidates 53,000 lawsuits.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 7:38 pm

ZTS

The European Commission has launched an investigation into Zoetis Inc (NYSE: ZTS) for potentially breaching competition rules by hindering the market launch of a competing dog pain medication. Zoetis' Librela, a novel treatment for osteoarthritis in dogs, is at the center of this probe. The investigation focuses on Zoetis' acquisition and subsequent discontinuation of a competing product, raising concerns about antitrust violations in the European Economic Area.

Portfolio Pulse from Vandana Singh

March 27, 2024 | 6:26 pm

HUM

WBA

Walgreens Boots Alliance Inc (WBA) is contesting a nearly $1 billion arbitration award to PWNHealth, alleging a breach of a COVID-19 test business contract. Walgreens argues the award is excessively high and exceeds the contract's damage limits. The dispute centers on Walgreens diverting COVID-19 tests from Everly's network to its operations. Additionally, Walgreens settled a lawsuit with Humana Inc (HUM) for $360 million over prescription drug reimbursement charges.

Portfolio Pulse from Vandana Singh

March 27, 2024 | 6:17 pm

DIS

GK

RSPC

Walt Disney Co (NYSE:DIS) and the Florida government, led by Gov. Ron DeSantis, have settled their legal disputes over the governance of Walt Disney World's special district. The settlement ends a two-year standoff related to Florida's 'Don't Say Gay' law, with Disney agreeing to work with the new board appointed by DeSantis. This agreement is expected to lead to significant investments and economic opportunities in Florida. Disney reported first-quarter revenue of $23.5 billion and an adjusted EPS of $1.22. DIS shares rose 0.31% to $120.30. Investors can also gain exposure to Disney through AdvisorShares Gerber Kawasaki ETF (NYSE:GK) and Invesco S&P 500 Equal Weight Communication Services ETF (NYSE:RSPC).

Portfolio Pulse from Anusuya Lahiri

March 27, 2024 | 6:00 pm

AZN

CVS

SNY

WBA

On Wednesday, Japan approved AstraZeneca Plc (NASDAQ:AZN) and Sanofi SA's (NASDAQ:SNY) Beyfortus for RSV in neonates, infants, and children, expected to be available for the 2024/25 RSV season. Additionally, AstraZeneca's Truqap was approved in Japan for certain breast cancers. AstraZeneca is also suing Arkansas over a law extending federal drug discounts to for-profit pharmacy chains like CVS Health Corp (NYSE:CVS) and Walgreens Boots Alliance Inc (NASDAQ:WBA), arguing it infringes on federal law and constitutional rights.

Portfolio Pulse from Vandana Singh

March 27, 2024 | 5:42 pm

COIN

The SEC has expressed satisfaction with a court's decision allowing its case against Coinbase to proceed. This development could have significant implications for Coinbase's operations and regulatory landscape.

Portfolio Pulse from Benzinga Newsdesk

March 27, 2024 | 5:13 pm

AAPL

VGT

XLK

Phil Schiller, Apple Inc's former chief marketing officer and a protege of Steve Jobs, is defending Apple's integrated ecosystem against global regulatory pushback, emphasizing security and privacy. Despite facing legal challenges from entities like the Justice Department, the EU, Spotify, and Microsoft, Schiller's efforts have been crucial in navigating antitrust litigation, notably with Epic Games over App Store policies. Apple remains focused on the Chinese market, planning to introduce its Vision Pro headset there by 2024, despite a decline in iPhone shipments. Apple's stock has dropped 9% YTD, but it recently saw a 1.59% increase to $172.41.

Portfolio Pulse from Anusuya Lahiri

March 27, 2024 | 3:51 pm